LNSR241220P2500
- 0.00
- 0.000.00%
LENSAR Newsroom
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day
US$9.00: That's What Analysts Think LENSAR, Inc. (NASDAQ:LNSR) Is Worth After Its Latest Results
Q3 2024 LENSAR Inc Earnings Call
BTIG Maintains LENSAR(LNSR.US) With Buy Rating, Raises Target Price to $10
LENSAR | 10-Q: Q3 2024 Earnings Report
LENSAR Q3 2024 GAAP EPS $(0.13) Beats $(0.27) Estimate, Sales $13.539M Beat $11.500M Estimate
Express News | Corrected-LENSAR Q3 Revenue USD 13.5 Million (Corrects Amount)
LENSAR | 8-K: LENSAR Reports Third Quarter 2024 Results and Provides Business Update
Express News | LENSAR Q3 Adjusted Ebitda USD 429 Thousand
Lensar 3Q Rev $13.5M >LNSR
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8
Earnings Preview: LENSAR to Report Financial Results Pre-market on November 07
$LENSAR(LNSR.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $LENSAR(LNSR.US)$ to post revenue of USD11.50M for 2024Q3, up 17.41%
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LENSAR to Participate in Two Upcoming Investor Conferences
LENSAR (LNSR) Gets a Buy From Lake Street
LENSAR Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
LENSAR | 10-Q: Q2 2024 Earnings Report